1.Eickhoff, TC, Sherman, IL, Serfling, RE. Observations on excess mortality associated with epidemic influenza. JAMA 1961; 176: 776–82.
2.Housworth, J, Langmuir, AD. Excess mortality from epidemic influenza, 1957–1966. Am J Epidem 1974; 100: 40–8.
3.Barker, WH, Mullooly, JP. Pneumonia and influenza deaths during epidemics. Implications for prevention. Arch Intern Med 1982; 142: 85–9.
4.Glezen, WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4: 25–44.
5. Immunisation against infectious disease. Joint Committee on Vaccination and Immunisation. Department of Health. 1990. London: Her Majesty's Stationery Office.
6.Nicholson, KG, Wiselka, MJ, May, A. Influenza vaccination of the elderly: perceptions and policies of general practitioners and outcome of the 1985–86 immunization programme in Trent, UK. Vaccine 1987; 5: 302–6.
7.Kurinczuk, JJ, Nicholson, KG. Uptake of influenza vaccination by patients with serious cardiac disease. Br Med J 1989; 299: 367.
8.Pachuki, CT, Lentino, JR, Jackson, GG. Attitudes and behaviour of health care personnel regarding the use and effiacy of influenza vaccine. J Infect Dis 1985; 151: 1170–1.
9.Kraaijeveld, CA, Reed, SE, Macnaughton, MR. Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with coronavirus 229E group viruses. J Clin Microbiol 1980; 12: 493–7.
10. Prospects for immunising against influenza viruses A and B. In: New vaccine development; establishing priorities. Vol 1. Diseases of importance in the United States. Division of Health Promotion and Disease Prevention. Institute of Medicine. National Academy Press. Washington 1985, 342–64.
11.Garvie, DG, Gray, J. Outbreak or respiratory syncytial virus infection in the elderly. Br Med J 1980; 281: 1253–4.
12.Communicable Disease Surveillance Centre. Respiratory syncytial virus infection in the elderly, 1976–1982. Br Med J 1983; 287: 1618–9.
13.Hart, RJC. An outbreak of respiratory syncytial virus infection in an old people's home. J Infect 1984; 8: 259–61.
14.Respiratory syncytial disease – Missouri. MMWR 1977; 26: 351.
15.Mathur, U, Bentley, DW, Hall, CB. Concurrent respiratory syncytial virus and influenza A infections in the institutionalised elderly and chronically ill. Ann Intern Med 1980; 93: 49–52.
16.Morales, F, Calder, MA, Inglis, JM, Murdoch, PS, Williamson, J. A study of respiratory infections in the elderly to assess the role of respiratory syncytial virus. J Infect 1983; 7: 236–47.
17.Sorvillo, FJ, Huie, SF, Strassburg, MA, Butsumyo, A, Shandera, WX, Fannin, SL. An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly. J Infect 1984; 9: 252–6.
18.Macnaughton, MR. Occurrence and frequency of coronavirus infections in humans as determined by enzyme-linked immunosorbent assay. Infect Immunity 1982; 38: 419–23.
19.Salk, JE, Rapalski, AJ. Evaluation of influenza vaccine in an explosive epidemic of mixed aetiology. US Armed Forces Medical Journal. 1958; 9: 469–78.
20.Kitamoto, O. Therapeutic effectiveness of amantadine hydrochloride in influenza A2. Double blind studies. Jap J Tuberc Chest Dis 1968; 15: 17–26.
21. Adult immunization. Recommendations of the immunization practices advisory committee. MMWR Supplement No. 1S, 1984; 33: 23s–26s.
22.Howells, CHL, Vesselinova-Jenkins, CK, Evans, AD, James, J. Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet 1985; i: 381–3.
23.Serie, C, Barme, M, Hannoun, C, Thibon, M, Beck, H, Aquino, JP. Effects of vaccination on an influenza epidemic in a geriatric hospital. Dev Biol Stand 1977; 39: 317–21.
24.Gross, PA, Quinnan, GV, Rodstein, M. Association of influenza immunisation with reduction in mortality in an elderly population. A prospective study. In Program and Abstracts of the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, Abstract No. 288.
25.Patriarca, PA, Weber, JA, Parker, Ra et al. , Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 1985; 253: 1136–9.
26.Nicholson, KG. Antiviral agents in clinical practice. Respiratory infections, genital herpes, and herpetic keratitis. Lancet 1984; ii: 617–21.